0001209191-19-039652.txt : 20190701 0001209191-19-039652.hdr.sgml : 20190701 20190701153636 ACCESSION NUMBER: 0001209191-19-039652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190627 FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waldin Jan-Paul CENTRAL INDEX KEY: 0001733176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 19933035 MAIL ADDRESS: STREET 1: 77 KING STREET WEST STREET 2: SUITE 3000 CITY: TORONTO STATE: A6 ZIP: M5K 1G8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-27 0 0001626878 XBiotech Inc. XBIT 0001733176 Waldin Jan-Paul 77 KING STREET WEST SUITE 3000 TORONTO A6 M5K 1G8 ONTARIO, CANADA 1 0 0 0 Stock Option 7.45 2019-06-27 4 A 0 25000 0.00 A 2019-12-27 2029-06-27 Common Stock 25000 25000 D On June 27, 2019 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions at six month and one year from the Grant Date with an expiry of ten years from the Grant Date. /s/ Queena Han under Power of Attorney for Jan-Paul Waldin 2019-07-01